424 related articles for article (PubMed ID: 20382194)
1. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
2. How to assess the mutagenic potential of cosmetic products without animal tests?
Speit G
Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
[TBL] [Abstract][Full Text] [Related]
3. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
4. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
5. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
[TBL] [Abstract][Full Text] [Related]
6. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the mutagenicity/genotoxicity data of the cosmetic ingredients present on the Annexes of the Cosmetic EU legislation (2000-12).
Ates G; Doktorova TY; Pauwels M; Rogiers V
Mutagenesis; 2014 Mar; 29(2):115-21. PubMed ID: 24435663
[TBL] [Abstract][Full Text] [Related]
8. The Cosmetics Europe strategy for animal-free genotoxicity testing: project status up-date.
Pfuhler S; Fautz R; Ouedraogo G; Latil A; Kenny J; Moore C; Diembeck W; Hewitt NJ; Reisinger K; Barroso J
Toxicol In Vitro; 2014 Feb; 28(1):18-23. PubMed ID: 23811264
[TBL] [Abstract][Full Text] [Related]
9. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.
Kirkland DJ; Aardema M; Banduhn N; Carmichael P; Fautz R; Meunier JR; Pfuhler S
Mutagenesis; 2007 May; 22(3):161-75. PubMed ID: 17369606
[TBL] [Abstract][Full Text] [Related]
10. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
11. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
12. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
[TBL] [Abstract][Full Text] [Related]
13. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
14. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
15. Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay.
Mun GC; Aardema MJ; Hu T; Barnett B; Kaluzhny Y; Klausner M; Karetsky V; Dahl EL; Curren RD
Mutat Res; 2009 Mar; 673(2):92-9. PubMed ID: 19167515
[TBL] [Abstract][Full Text] [Related]
16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
17. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
[TBL] [Abstract][Full Text] [Related]
18. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
20. Way forward in case of a false positive in vitro genotoxicity result for a cosmetic substance?
Doktorova TY; Ates G; Vinken M; Vanhaecke T; Rogiers V
Toxicol In Vitro; 2014 Feb; 28(1):54-9. PubMed ID: 24095862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
